Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane Wasman currently holds 18,250 shares of SELLAS Life Sciences Group, Inc. (SLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane Wasman has been a net seller of SLS stock. They have purchased $0 and sold $8.4M worth of shares.
Jane Wasman's most recent insider trade was on May 15, 2026, when they sold 5,750 shares at $0.00 per share.
Jane Wasman serves as Executive at SELLAS Life Sciences Group, Inc. (SLS). They have executed 256 insider transactions totaling $8.4M over their tenure at the company.
Jane Wasman holds the position of Executive at SELLAS Life Sciences Group, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jane Wasman has shown a selling trading pattern, with $0 in total purchases and $8.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jane Wasman was on Feb 9, 2017, when they sold $1.2M worth of ACOR shares. This transaction involved 54,536 shares at $22.30 per share.
Jane Wasman currently owns 18,250 shares of SELLAS Life Sciences Group, Inc. (SLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane Wasman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane Wasman has 256 Form 4 filings on record as an insider at SELLAS Life Sciences Group, Inc..
Set alerts for Jane Wasman and 40,000+ other insiders.